UPDATE 1-L&T sees signs of Indian push on infrastructure

Thu Jan 24, 2013 6:52pm IST

Stocks

   

* On track to meet 15-20 pct growth in full-year orders

* Q3 net profit up 13 percent on strong order wins

* Seeing delay in payment from clients (Adds detail, executive quotes, background)

By Kaustubh Kulkarni and Aditi Shah

MUMBAI, Jan 24 (Reuters) - Indian construction and engineering group Larsen & Toubro beat forecasts for quarterly profit and it was seeing early signs of a government push on infrastructure spending which could boost future orders.

Sluggish industrial capital expenditure has squeezed orders for engineering majors such as L&T and Bharat Heavy Electricals , while big ticket energy and infrastructure projects in the country have been stalled by a host of factors.

In September, the government announced reforms aimed at attracting more foreign investment in infrastructure and cutting back on budget-busting subsidies in Asia's third-largest economy where the rate of growth is near a 10-year low.

"There are early signs of a government push on infrastructure investments," L&T chief financial officer R Shankar Raman said on Thursday.

L&T said net profit rose 13 percent rise to 11.2 billion rupees ($209 million) in the three months to December - its third quarter - on the back of strong order wins. That compared with a Thomson Reuters I/B/E/S forecast for 10.8 billion rupees.

Sales rose 10 percent to 154 billion rupees, against a forecast for 161 billion.

The company, whose order book is regarded as a bellwether for corporate confidence in the economy, said it should meet guidance for 15-20 percent order book growth in the full year to March.

L&T, whose order book stood at 1.62 trillion rupees at the end of December, said it expected to win orders worth 200-250 billion rupees in the January-March period.

It won new orders worth 195 billion rupees in its third quarter, up 14 percent year-on-year.

While there has been a delay in payment from some clients, there was no threat of default, it said. ($1 = 53.6850 rupees) (Editing by Dan Lalor)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

 G20 Meet

G20 Meet

As G20 chases growth goal, members differ on how to get there   Full Article 

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Alibaba Listing

Alibaba Listing

Alibaba surges on massive demand in trading debut  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Apple Not Cool?

Apple Not Cool?

Some consumers say Apple is losing its "cool" factor  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage